Interdisciplinary management of an intraductal papillary mucinous neoplasm of the pancreas

Cancer Control

Volumn 15, Issue 4, 2008, Pages 322-333

  Nair, Rajesh M ^a   Barthel, James S ^a   Centeno, Barbara A ^a   Choi, Junsung ^a   Klapman, Jason B ^a   Malafa, Mokenge P ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AGED; ARTICLE; CANCER RISK; CASE REPORT; CLINICAL FEATURE; CYTOLOGY; DECISION MAKING; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LIFE EXPECTANCY; MEDICAL LITERATURE; MORBIDITY; PANCREAS RESECTION; PANCREAS SURGERY; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

EID: 55249127540     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480801500407     Document Type: Article

References (51)

1. Khalid A, McGrath KM, Zahid M, et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol. 2005;3(10):967-973.
2. Taouli B, Vilgrain V, O'Toole D, et al. Intraductal papillary mucinous tumors of the pancreas: features with multimodality imaging. J Comput Assist Tomogr. 2002;26(2):223-231.
3. Kawarada Y, Yano T, Yamamoto T, et al. Intraductal mucin-producing tumors of the pancreas. Am J Gastroenterol. 1992;87(5):634-638.
4. Traverso LW, Peralta EA, Ryan JA Jr, et al. Intraductal neoplasms of the pancreas. Am J Surg. 1998;175(5):426-432.
5. Kawamoto S, Horton KM, Lawler LP, et al. Intraductal papillary mucinous neoplasm of the pancreas: can benign lesions be differentiated from malignant lesions with multidetector CT? Radiographics. 2005;25(6):1451-1468; discussion 1468-1470.
6. Sugiyama M, Atomi Y, Kuroda A. Two types of mucin-producing cystic tumors of the pancreas: diagnosis and treatment. Surgery. 1997;122(3):617-625.
7. Fukukura Y, Fujiyoshi F, Sasaki M, et al. Intraductal papillary mucinous tumors of the pancreas: thin-section helical CT findings. AJR Am J Roentgenol. 2000;174(2):441-447.
8. Heinrich S, Goerres GW, Schäfer M, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg. 2005;242(2):235-243.
9. Mansour JC, Schwartz L, Pandit-Taskar N, et al. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg. 2006;10(10):1354-1360.
10. Sperti C, Bissoli S, Pasquali C, et al. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2007;246(6):932-937; discussion 937-939.
11. Sperti C, Pasquali C, Fiore V, et al. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms. Am J Surg. 2006;191(6):743-748.
12. Yoshioka M, Sato T, Furuya T, et al. Positron emission tomography with 2-deoxy-2-[(18)F] fluoro-d-glucose for diagnosis of intraductal papillary mucinous tumor of the pancreas with parenchymal invasion. J Gastroenterol. 2003;38(12):1189-1193.
13. Azar C, Van de Stadt J, Rickaert F, et al. Intraductal papillary mucinous tumours of the pancreas: clinical and therapeutic issues in 32 patients. Gut. 1996;39(3):457-464.
14. Bilbao MK, Dotter CT, Lee TG. Complications of endoscopic retrograde cholangiopancreatography (ERCP): a study of 10,000 cases. Gastroenterology. 1976;70(3):314-320.
15. Fukukura Y, Fujiyoshi F, Sasaki M, et al. HASTE MR cholangiopancreatography in the evaluation of intraductal papillary-mucinous tumors of the pancreas. J Comput Assist Tomogr. 1999;23(2):301-305.
16. Koito K, Namieno T, Ichimura T, et al. Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography. Radiology. 1998;208(1):231-237.
17. Sahani DV, Kadavigere R, Blake M. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations. Correlation with MRCP. Radiology. 2006;238(2):560-569.
18. Gress F, Michael H, Gelrud D, et al. EUS-guided fine-needle aspiration of the pancreas: evaluation of pancreatitis as a complication. Gastrointest Endosc. 2002;56(6):864-867.
19. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004;126(5):1330-1336.
20. Fujino Y, Matsumoto I, Ueda T, et al. Proposed new score predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas. Am J Surg. 2007;194(3):304-307.
21. Wiesenauer CA, Schmidt CM, Cummings OW, et al. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg. 2003;138(6):610-617; discussion 617-618.
22. Raut CP, Cleary KR, Staerkel GA, et al. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol. 2006;13(4):582-594. Epub 2006 Mar 7.
23. Yang AD, Melstrom LG, Bentrem DJ, et al. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007;142(4):529-534; discussion 534-537.
24. Paye F, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery. 2000;127(5):536-544.
25. Kimura W, Sasahira N, Yoshikawa T, et al. Duct-ectatic type of mucin producing tumor of the pancreas: new concept of pancreatic neoplasia. Hepatogastroenterology. 1996;43(9):692-709.
26. Yamaguchi K, Ogawa Y, Chijiiwa K, et al. Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively. Am J Surg. 1996;171(4):427-431.
27. Partensky C, Berger F. Les tumeurs intracanalaires papillaires et mucineuses du pancréas. In: Le Borgne J, de Calan L, Partensky C, eds. Les Tumeurs Kystiques du Pancréas. Paris, France: Arnette Blackwell; 1997:90-107.
28. Maire F, Couvelard A, Hammel P, et al. Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc. 2003;58(5):701-706.
29. White R, D'Angelica M, Katabi N, et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg. 2007;204(5):987-993; discussion 993-995. Epub 2007 Mar 27.
30. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6(1-2):17-32.
31. Atia GN, Brown RD, Alrashid A, et al. The role of pancreatoscopy in the preoperative evaluation of intraductal papillary mucinous tumor of the pancreas. J Clin Gastroenterol. 2002;35(2):175-179.
32. Itoi T, Sofuni A, Itokawa F, et al. Initial experience of peroral pancreatoscopy combined with narrow-band imaging in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas (with videos). Gastrointest Endosc. 2007;66(4):793-797.
33. Venu RP, Atia G, Brown RD, et al. Intraductal papillary mucinous tumor of the pancreas: ERCP, EUS, and pancreatoscopy findings. Gastrointest Endosc. 2002;55(1):82.
34. Yasuda K, Sakata M, Ueda M, et al. The use of pancreatoscopy in the diagnosis of intraductal papillary mucinous tumor lesions of the pancreas. Clin Gastroenterol Hepatol. 2005;3(7 suppl 1):S53-S57.
35. Hruban RH, Takaori K, Klimstra DS, et al An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28(8):977-987.
36. Hruban RH, Pitman MB, Klimstra DS, et al. Armed Forces Institute of Pathology Atlas of Tumor Pathology: Tumors of the Pancreas. Washington DC: American Registry of Pathology; 2007.
37. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol. 2000;157(3):755-761.
38. Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas: pathology and molecular genetics. J Gastrointest Surg. 2002;6(5):656-659.
39. D'Angelica M, Brennan MF, Suriawinata AA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg. 2004;239(3):400-408.
40. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239(6):788-797; discussion 797-799.
41. Nakagohri T, Asano T, Kenmochi T, et al. Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas. World J Surg. 2002;26(9):1166-1169. Epub 2002 Jun 6.
42. Salvia R, Fernández-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239(5):678-685; discussion 685-687.
43. Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123(5):1500-1507.
44. Takahashi H, Nakamori S, Nakahira S, et al. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas. Ann Surg Oncol. 2006;13(7):955-960. Epub 2006 May 18.
45. Yokoyama Y, Nagino M, Oda K, et al. Clinicopathologic features of re-resected cases of intraductal papillary mucinous neoplasms (IPMNs). Surgery. 2007;142(2):136-142.
46. Wada K, Takada T, Yasuda H, et al. Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas? J Gastrointest Surg. 2004;8(3):289-296.
47. Salvia R, Crippa S, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut. 2007;56(8):1086-1090. Epub 2006 Nov 24.
48. Sugiyama M, Atomi Y. Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol. 1999;94(2):470-473.
49. Kamisawa T, Tu Y, Egawa N, et al. Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol. 2005;11(36):5688-5690.
50. Choi MG, Kim SW, Han SS, et al. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms. Arch Surg. 2006;141(1):51-56; discussion 56.
51. Eguchi H, Ishikawa O, Ohigashi H, et al. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development. Surgery. 2006;139(6):749-754.